Venus Remedies Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock of Venus Remedies Ltd hit its upper circuit price band of 5% on 25 May 2026, closing at Rs 1,136.15. This price band capped the maximum daily gain allowed, effectively freezing trading at the ceiling price. The total traded volume was 43,786 shares, with a turnover of approximately Rs 4.95 crore. The upper circuit event indicates that demand exceeded what the price band could accommodate, leaving unfilled buy orders at the close. This scenario is typical when buyers are eager to accumulate but sellers are reluctant to sell at lower prices, creating a supply-demand imbalance that the exchange's price band mechanism enforces. Venus Remedies Ltd thus experienced a session where the exchange ceiling stopped the rally, not the buyers — what does the full demand picture look like for Venus Remedies Ltd once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Delivery volumes provide the clearest insight into the quality of a circuit move. On 22 May 2026, delivery volume for Venus Remedies Ltd rose sharply to 67,280 shares, marking a 76.98% increase against the five-day average delivery volume. This surge in delivery volume suggests that the shares traded were largely taken into investors' demat accounts, signalling genuine buying conviction rather than intraday speculative trading. Although the total traded volume on the circuit day was mechanically suppressed due to the price lock, the rising delivery component confirms that the buying pressure was backed by investors willing to hold the stock. This is a significant distinction, as volume on a circuit day is often lower than usual, but delivery volume rising is a strong positive indicator — is Venus Remedies Ltd's 5% surge backed by improving fundamentals or is this a liquidity-driven micro-cap move?

Moving Averages and Trend Context

Venus Remedies Ltd is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment confirms a strong bullish trend that preceded the upper circuit event. The stock has been gaining for two consecutive days, accumulating a 10.25% return in this period. The 5% gain on 25 May 2026 further cements this momentum, with the stock opening with a gap up of 4.1% and touching an intraday high at the circuit price of Rs 1,136.15. The narrow intraday range between Rs 1,113.70 and Rs 1,136.15 reflects the price lock mechanism, but the trend structure supports the breakout — how sustainable is this trend given the micro-cap nature of the stock?

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately Rs 1,518.69 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with the stock liquid enough to support a trade size of Rs 0.16 crore based on 2% of the five-day average traded value. While this level of liquidity is sufficient for retail and small institutional participation, it remains limited compared to larger caps. This thin liquidity means that upper circuit events carry a dual message: they reflect genuine buying interest but also highlight the difficulty of entering or exiting sizeable positions without impacting the price. For micro-caps like Venus Remedies Ltd, this liquidity risk is as important as the momentum signal itself, especially when the stock hits its maximum allowed daily gain.

Intraday Price Action

The intraday price range on 25 May 2026 was relatively narrow, with a low of Rs 1,113.70 and a high of Rs 1,136.15, the latter being the upper circuit price. The stock opened with a gap up of 4.1%, indicating strong overnight or early session buying interest. The price then steadily climbed to the circuit limit, where it remained locked for the rest of the session. This pattern is typical for stocks hitting upper circuits, where the price band restricts further upward movement despite persistent demand. The limited intraday volatility near the circuit price suggests that buyers were willing to transact only at the ceiling price, while sellers were absent, reinforcing the unfilled demand narrative.

Brief Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by innovation and regulatory dynamics. While the stock's recent price action is primarily technical, the sector's growth prospects and the company's positioning within it provide a backdrop for investor interest. However, the upper circuit event and delivery volume surge on 25 May 2026 are more reflective of market mechanics and liquidity conditions than immediate fundamental shifts.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at Rs 1,136.15 with a 5.0% gain, combined with a 76.98% rise in delivery volume against the five-day average, signals genuine buying conviction in Venus Remedies Ltd. The stock's position above all major moving averages further confirms a bullish trend. However, as a micro-cap with moderate liquidity, the stock carries inherent liquidity risk — the thin order book and limited trade size mean that while the momentum is clear, entering or exiting large positions could prove challenging. The circuit locked in gains but also locked out buyers who arrived late, leaving unfilled demand that will be closely watched when trading resumes. After a 5% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?

Only Rs. 20,999 - Get MojoOne + Stock of the Week for 3 Years Get 71% Off →